Drug Patent Watch

JUNE 8, 2021

When it comes to pricing generic drugs, there are a number of factors that come into play. In countries without drug price regulations, the pricing is based largely on profitability.…. The post Strategies for Pricing Generic Drugs appeared first on DrugPatentWatch - Make Better Decisions.

Generic Drugs 66

Generic Drugs Drugs Regulation 66

BioSpace

JANUARY 14, 2021

Billionaire entrepreneur Mark Cuban, best known as the owner of the Dallas Mavericks and an investor on the ABC business reality series “Shark Tank,” is diving into generic drugs with a new startup, dubbed Mark Cuban Cost Plus Drug Company.

Generic Drugs 90

Generic Drugs Drugs Marketing 90

Scienmag

JUNE 20, 2022

billion by purchasing generic drugs at Mark Cuban prices Abstract: [link] URL goes live when the embargo lifts A brief research report found that Medicare could have saved up to $3.6 billion by purchasing generic drugs at the same prices as the Mark Cuban Cost Plus Drug […]. Medicare could save up to $3.6

Generic Drugs 67

Generic Drugs Drugs Research 67

Drug Channels

JUNE 22, 2022

In the video below, I discuss how generic drug pricing and the rise of patient-paid, discount card prescriptions pose a risk to pharmacy benefit plans and the PBM business. Recently, I explored the complex web of relationships and conflicts that support today’s discount card economics.

Generic Drugs 75

Generic Drugs Drugs Pharmacy 75

The Pharma Data

MAY 5, 2021

FDA officials said that the number of a product specific guidances (PSGs) issued by the Office of Generic Drugs (OGD) has increased steadily since FY 2013. FDA webinar on product specific guidance for generic drugs . In FY 2019, 252 were issued, as were 208 in FY 2018. . Source link.

Generic Drugs 52

Generic Drugs Drugs Development Research 52

Drug Patent Watch

AUGUST 12, 2020

Just because a drug has received FDA approval does not mean that it is available in the marketplace. The post Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market appeared first on DrugPatentWatch - Make Better Decisions.

Generic Drugs 52

Generic Drugs Drugs FDA Approval Marketing 52

BioSpace

AUGUST 21, 2023

Three years after the initial case, Teva Pharmaceuticals is finally settling its drug price-fixing charges with the Department of Justice for $225 million, payable over a five-year period.

Generic Drugs 98

Generic Drugs Drugs 98

Pharmaceutical Technology

MAY 3, 2023

Since 2015, the US Food and Drug Administration (FDA) has approved more than 450 “first generics” or the first generic equivalent for a branded drug. These medicines comprise about 10% of all generics approved each year. Still, the FDA does prioritize the review of submissions for first generics.

Generic Drugs 246

Generic Drugs Drugs Medicine FDA Approval 246

Fierce Pharma

AUGUST 31, 2023

recently made comments about the untenable nature of generic drug production in the U.S., recently made comments about the untenable nature of generic drug production in the U.S., After FDA Commissioner Robert Califf, M.D., a clutch of governors has raised its own set of concerns about shortages.

Generic Drugs 115

Generic Drugs Drugs Production 115

BioSpace

NOVEMBER 29, 2020

For the medical industry, China's proposed patent linkage system can be more favorable to generic drug companies than the U.S. The fourth Amendment of the China Patent Law has been deliberated and was passed on October 17, 2020. It will come into force on June 1, 2021.

Generic Drugs 75

Generic Drugs Drugs 75

Bio Pharma Dive

JULY 18, 2023

The pharma company, which will soon split off its generic drug unit, plans to repurchase up to $15 billion of its shares through the end of 2025.

Generic Drugs 130

Generic Drugs Drugs Pharma Companies Sales 130

BioTech 365

MAY 28, 2021

Global Generic Drugs Market Report 2021: The New Generics Era – The Patent Cliff, Types of Generic Drugs, Simple Generics, Super Generics, Biosimilars, ANDA Approvals – ResearchAndMarkets.com Global Generic Drugs Market Report 2021: The New Generics Era – The Patent … Continue reading →

Generic Drugs 40

Generic Drugs Drugs Marketing 40

Drug Patent Watch

SEPTEMBER 15, 2020

This likely means fewer generic entrants and less opportunities for consumers to enjoy…. The post Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs appeared first on DrugPatentWatch - Make Better Decisions.

Generic Drugs 52

Generic Drugs Drugs 52

BioTech 365

OCTOBER 1, 2021

Regarding Generic Drugs Sandoz Resolves Legacy Federal Government Civil Investigation in the U.S. Regarding Generic Drugs Company previously disclosed settlement agreement in principle and fully provisioned for this resolution Basel, … Continue reading →

Generic Drugs 40

Generic Drugs Drugs 40

BioTech 365

JUNE 25, 2021

GCC Generic Drug Market Trends, Share, Size, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com GCC Generic Drug Market Trends, Share, Size, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast (..)

Generic Drugs 40

Generic Drugs Drugs Marketing 40

BioSpace

AUGUST 30, 2023

Amid a supply shortage of the attention-deficit/hyperactivity disorder and binge-eating disorder medication, the regulator has cleared a slew of generic drugs of Takeda’s Vyvanse pill.

FDA Approval 111

FDA Approval Generic Drugs Drugs Regulation 111

BioTech 365

OCTOBER 4, 2021

Canada Generic Drug Market Industry Trends, Share, Size, Growth, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com Canada Generic Drug Market Industry Trends, Share, Size, Growth, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Canada Generic Drug Market: Industry Trends, (..)

Generic Drugs 40

Generic Drugs Drugs Marketing 40

NY Times

SEPTEMBER 18, 2021

Competition for market share at rock-bottom prices has led to shortages, price-spikes, allegations of price-fixing, and substandard and even dangerous practices.

Generic Drugs 96

Generic Drugs Drugs Marketing Manufacturing 96

BioTech 365

NOVEMBER 18, 2021

Brazil Generic Drug Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Forecast and Opportunities – ResearchAndMarkets.com Brazil Generic Drug Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Forecast and Opportunities – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Brazil Generic (..)

Generic Drugs 40

Generic Drugs Drugs Marketing 40

STAT News

MARCH 10, 2023

Revelations that AbbVie, the manufacturer of Humira, made more than $100 billion in extra profits by abusing the patent system to delay generic competition has spurred efforts by the Biden administration and Congress to limit the length of patent monopolies over prescription drugs.

Generic Drugs 98

Generic Drugs Drugs Manufacturing 98

BioSpace

AUGUST 29, 2023

Lupin Pharmaceuticals' recall of Tydemy birth control is the latest in a string of problems with India-based generic drug manufacturers.

Drugs 106

Drugs Generic Drugs Manufacturing 106

Pharmaceutical Technology

SEPTEMBER 15, 2022

increase in revenue from 2020 to 2021 from sales of Revlimid, its multiple myeloma therapy, with a global analyst consensus sales forecast of $12.8bn for 2021, according to GlobalData’s Drugs Database. However, other challenges facing biopharmaceutical companies include growing generic drug competition, which places pressure on drug prices.

Vaccination 272

Vaccination Vaccine Generic Drugs Drugs 272

Pharmacy Checkers

JULY 11, 2019

I’m proud to share that PharmacyChecker has published a white paper that examines prices and availability of newly approved generic drugs. Our report, based on 40 generic medications that were approved from 2017-2018, clearly shows that generic drug approvals often don’t lead to greater affordability or even access here in the U.S.

Generic Drugs 48

Generic Drugs FDA Approval Drugs Pharmacy 48

Pharmaceutical Technology

APRIL 4, 2023

Indian pharma manufacturing continues to be the backbone of drug supplies worldwide, and GlobalData analysis suggests US overreliance on the country for generic drug supply. US reliance on India for generic drugs could have supply chain security and quality implications for critical medicines.

Manufacturing 130

Manufacturing Generic Drugs Gene Therapy Contract Manufacturing 130

BioTech 365

APRIL 28, 2021

United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … Continue reading (..)

Generic Drugs 40

Generic Drugs Drugs Branding 40

Medical Xpress

APRIL 19, 2023

Since the overturning of Roe v. Wade in June 2022 and the end of constitutional protection for abortion, emergency contraception has become more difficult to obtain and—more than ever—shrouded in misinformation.

Generic Drugs 66

Generic Drugs Drugs 66

BioTech 365

APRIL 26, 2021

United States Generic Drugs Market Report 2020-2026: Focus on CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Anti-infective & Oncology – ResearchAndMarkets.com United States Generic Drugs Market Report 2020-2026: Focus on CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Anti-infective & (..)

Generic Drugs 40

Generic Drugs Dermatology Hormones Drugs 40

BioTech 365

FEBRUARY 3, 2021

This New Year, SMB Generic Drug Manufacturers Take Back Control with MDH Insight’s Trailblazing EmpowerRM® Pharma Chargeback Software This New Year, SMB Generic Drug Manufacturers Take Back Control with MDH Insight’s Trailblazing EmpowerRM® Pharma Chargeback Software PEMBROKE PINES, Fla.–(BUSINESS

Generic Drugs 52

Generic Drugs Drugs Manufacturing 52

BioTech 365

JANUARY 7, 2021

Demand Management Solution Helps a Generic Drugs Manufacturer Reduce Costs and Address Supply Chain Complexities | Infiniti’s Recent Client Engagement Demand Management Solution Helps a Generic Drugs Manufacturer Reduce Costs and Address Supply Chain Complexities | Infiniti’s Recent Client Engagement … Continue reading →

Generic Drugs 52

Generic Drugs Drugs Manufacturing 52

Bio Pharma Dive

OCTOBER 26, 2021

The generic drug unit has struggled in recent years, while Novartis has moved to focus more narrowly on higher-margin branded medicines.

Generic Drugs 176

Generic Drugs Medicine Drugs Sales 176

Fierce Pharma

JULY 31, 2023

The case hinges on charges Viatris accrued in patent litigation tied to its generic drug approvals in the 2010s. . | Viatris has successfully held its ground in a pitched battle with the Internal Revenue Service over tens of millions of dollars.

Generic Drugs 98

Generic Drugs Drugs 98

STAT News

DECEMBER 13, 2022

WASHINGTON — The Biden administration signaled Monday that it will require health plans on federal exchanges to cover more of the costs of generic drugs, a small tweak that nevertheless has industry groups divided on how best to manage drug costs. Continue to STAT+ to read the full story…

Generic Drugs 98

Generic Drugs Drugs Regulation 98

BioTech 365

APRIL 15, 2021

Global Generic Drugs (Small Molecule Generics vs Biosimilars) Market Forecast & Opportunities, 2021-2026 by Application, Drug Delivery, Form, Source, Distribution Channel – ResearchAndMarkets.com Global Generic Drugs (Small Molecule Generics vs Biosimilars) Market Forecast & Opportunities, 2021-2026 by Application, Drug Delivery, … (..)

Generic Drugs 40

Generic Drugs Drug Delivery Drugs Marketing 40

Drug Patent Watch

OCTOBER 29, 2019

The post Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984 appeared first on DrugPatentWatch - Make Better Decisions. This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under a creative commons license.

Generic Drugs 53

Generic Drugs Drugs Development Licensing 53

Bio Pharma Dive

JULY 9, 2021

The executive order issued Friday calls on regulators to "enforce the antitrust laws vigorously" and to ban the controversial agreements that can slow the arrival of generic drugs.

Generic Drugs 157

Generic Drugs Drugs Regulation 157

Bio Pharma Dive

JUNE 16, 2021

The subsidiary of hospital-owned nonprofit CivicaRx plans to make six to 10 common generic drugs that don't have enough competition to drive down cost.

Generic Drugs 157

Generic Drugs Drugs 157

STAT News

DECEMBER 14, 2022

… The Biden administration signaled it will require health plans on federal exchanges to cover more of the costs of generic drugs, a small tweak that nevertheless has industry groups divided on how best to manage drug costs , STAT reports. The Continue to STAT+ to read the full story…

Generic Drugs 98

Generic Drugs Drugs Vaccination Vaccine 98